Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin.

about

Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics.Use of a Caco-2 permeability assay to evaluate the effects of several Kampo medicines on the drug transporter P-glycoprotein

P2860

Q50119590-6DD70266-3BEF-4331-9B93-746ADCE37287 Q57764177-C2458E8A-296E-43BA-A21C-43BC876348AC

P2860

Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin.

Item

http://www.wikidata.org/entity/Q47610956

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Clinical evaluation of P-glyco ...... nteraction study with digoxin.

@en

Clinical evaluation of P-glyco ...... nteraction study with digoxin.

@nl

type

Item

label

Clinical evaluation of P-glyco ...... nteraction study with digoxin.

@en

Clinical evaluation of P-glyco ...... nteraction study with digoxin.

@nl

prefLabel

Clinical evaluation of P-glyco ...... nteraction study with digoxin.

@en

Clinical evaluation of P-glyco ...... nteraction study with digoxin.

@nl

P1476

Clinical evaluation of P-glyco ...... nteraction study with digoxin.

@en

P2093

Ahmed Hamed Salem

http://www.w3.org/2001/XMLSchema#string

Bo Tong

http://www.w3.org/2001/XMLSchema#string

Manoj S Chiney

http://www.w3.org/2001/XMLSchema#string

Orlando F Bueno

http://www.w3.org/2001/XMLSchema#string

Rajeev M Menon

http://www.w3.org/2001/XMLSchema#string

P2860

Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics

Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver

Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study

Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.

Sirolimus-associated pulmonary toxicity.

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.

Mechanisms, manifestations, and management of digoxin toxicity in the modern era.

A semi-mechanistic absorption model to evaluate drug-drug interaction with dabigatran: application with clarithromycin.

Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00498254.2017.1381779

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29027832

http://www.w3.org/2001/XMLSchema#string

P921

digoxin

Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin.

about

P2860

P2860

Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P577

P698

P921